Mar 10, 2016 8:00 am EST Capricor Therapeutics to Hold Fourth Quarter 2015 Financial Results and Business Update Conference Call on March 17, 2016 at 4:30 p.m. EDT
Feb 23, 2016 9:00 am EST Capricor Therapeutics Appoints Leland J. Gershell, M.D., Ph.D. as Chief Financial Officer
Feb 22, 2016 8:00 am EST Capricor Therapeutics Announces the First Patient with Duchenne Muscular Dystrophy-Related Cardiomyopathy Treated with CAP-1002 in the HOPE-Duchenne Phase I/II Clinical Trial
Feb 02, 2016 7:00 am EST Capricor Therapeutics to Present at 18th Annual BIO CEO & Investor Conference
Nov 24, 2015 7:00 am EST Capricor Therapeutics to Present at the 2015 Piper Jaffray Healthcare Conference
Nov 12, 2015 4:05 pm EST Capricor Therapeutics Reports Third Quarter 2015 Business & Financial Highlights